Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by askretkaon Nov 12, 2022 7:19am
442 Views
Post# 35093392

Pelareorep Cost

Pelareorep Cost
While as Canadafan said no company is going to reveal that this early in game we got a hint that Pelareorep is fairly cheap to produce. They said in regards to CAR-T + Pelareorep they would be looking for up front payment, milestones and a percentage of the overall CAR-T treatment BECAUSE ** they would only require two vials of Pelareorep one with initial CAR-T and then a Pelareorep boost shot after and it wouldn't be worth it to them to just sell two vials of Pelareorep per CAR-T patient. -------------------------------------- So I think they kinda let the cat out of the bag here that Pelareorep is pretty cheap to produce. Which is very good for us. CHEERS!!!!!
<< Previous
Bullboard Posts
Next >>